Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 251 - 300 out of 2,213

Document Document Title
WO/1990/009974A1
4-Substituted anthracyclinones of general formula (I), wherein R represents a hydrogen atom or a COOR1 group in which R1 may be a hydrogen atom or an optionally substituted C1-C10 alkyl group, which are intermediates in the preparation o...  
WO/1990/008759A1
The present invention concerns compounds of formula (I) wherein R1 is hydrogen, a hydroxy group or a methoxy group; R2 is hydrogen or a methyl group; R3 is hydrogen or a methyl group; Y is a secondary amino group (NHalkyl) or a tertiary ...  
WO/1990/007479A1
A method of obtaining bromated aromatic and heterocyclic combinations containing acceptor groups provides for bromination of aromatic and heterocyclic combinations, containing acceptor groups, with bromine or hydrobromic acid, the proces...  
WO/1990/004601A1
4-substituted anthracyclinones of formula (I), wherein R represents a straight or branched alkyl, alkenyl or alkynyl group of up to 16 carbon atoms optionally substituted by (a) an aryl group which is unsubstituted or substituted by an i...  
WO1989002886A3  
WO/1989/002886A2
The new 2-neopentylanthraquinone compound, which is produced by Friedel-Crafts acylation of neopenthylbenzene with phthalic anhydride followed by cyclization of the 2-(4-neopentylbenzoyl) benzoic acid obtained in the presence of strong a...  
WO/1989/001329A1
Pharmaceutical formulations comprising aromatic polycyclic dione compounds useful for treating mammals suffering from diseases caused by retroviruses are disclosed herein. A method for treating mammals suffering from retrovirus infection...  
WO/1988/008415A1
A method for producing a compound of formula (I) (wherein R1 and R2 each stand for a lower alkyl group; n denotes an integer of 0 to 21; X stands for hydrogen atom or an optionally protected hydroxyl group; and Y stands for an optionally...  
WO1987001698A3  
WO/1987/001698A2
Novel 1,4-naphthalenediol and 1,4-hydroquinone derivatives of formulas (I, II, III and IV) and their therapeutic uses as 5-lipoxygenase inhibitors, leukotriene inhibitors, antiinflammatory and/or inhibitors of mucus secretion agents. Als...  
WO/1986/004503A1
A pharmaceutical composition, comprising: Coenzyme Q10 (ubidecarenone) 2-17% by weight; Lecithin 50-70% by weight; Surfactant agent 20-48% by weight. The surfactant agent has a melting point comprised between 35 and 55oC and a HLB value ...  
WO/1986/004058A1
Quinone derivatives represented by general formula (I), wherein R1 and R2 may be the same or different and each represents hydrogen, methyl or methoxy or, when taken together, R1 and R2 represent -CH=CH-CH=CH-, R3 represents hydrogen or ...  
WO/1986/000887A1
Quinone derivatives represented by general formula (I) wherein R1 and R2 may be the same or different, and each represents hydrogen, methyl or methoxy or, when taken together, R1 and R2 represent -CH=CH-CH=CH-, R3 represents hydrogen or ...  
WO/1985/001726A1
A compound of formula II and tautomeric forms thereof wherein: R1 - R4 are H, alkyl, aryl, alkaryl, halogen, hydroxy, alkoxy, aryloxy, aralkoxy, acyloxy, amino or alkylamino; R8 has the same meaning as given to R1 - R4 or may be glycosyl...  
WO/1984/004300A1
A process for removing unalkylated anthraquinones from alkylated anthraquinone by forming a solution thereof, reducing the solution sufficiently so that at least part of the unalkylated anthraquinone is in the reduced form and extracting...  
WO/1982/003625A1
An inactivation of the catalytic system easily occurs during the oxidation of reactive aromatics by means of molecular oxygen, in a carboxylic acid solution and in presence of a catalyst which, consists itself of a cobalt compound with o...  
WO/1981/002797A1
Phenolic and naphtholic compounds have been found to be useful as dye forming developers in photographic silver halide constructions. The dye forming developers form dye images upon oxidation and do not require the presence of couplers i...  
WO/1981/002574A1
1, 4-naphthoquinone derivatives represented by the following general formula: (FORMULA) (wherein R1 represents a hydrogen atom, a hydroxy group, a lower alkoxy group or an arylthio group, R2 represents a carboxy group, an esterified carb...  
WO/1980/000340A1
In a process for purifying naphthoquinone obtained by gas phase catalytic oxidation of naphthalene, the improvement which comprises contacting a solution of the naphthoquinone dissolved in a solvent capable of dissolving naphthoquinone a...  
JP2014169334A  
JP2014522378A  
JP2014520894A  
JP5575350B2  
JP5567499B2  
JP5524043B2  
JP2014080578A
To provide a coloring composition that exhibits a high color value and excellent heat and light resistance; and a photosensitive coloring composition.A coloring composition contains: a phthalocyanine compound (A) represented by the speci...  
JP2014510698A  
JP5479175B2  
JP2014058569A
To provide a (hetero)aryl-p-quinone derivative for a treatment of mitochondrial diseases.Methods of treating or inhibiting mitochondrial diseases, for example friedreich ataxia (FRDA), Leber's hereditary optic neuropathy (LHON), mitochon...  
JP2014051432A
To provide an anthraquinone composition having stability to reduction, oxidation and hydrolysis in producing hydrogen peroxide by an anthraquinone method, high solubility to an organic solvent, and further preferably used as a medium sup...  
JP5442977B2  
JP5441668B2  
JP5424613B2  
JP5417708B2  
JP5374162B2  
JP5362759B2  
JP5364372B2  
JP5339040B2  
JP5339041B2  
JP5334169B2  
JP5318347B2  
JP5306653B2  
JP2013194045A
To find a new compound having a DNA polymerase inhibitory activity, and to provide a new pharmaceutical composition utilizing the same compound.A new compound having a DNA polymerase inhibitory activity is separated from a mold parasitic...  
JP2013170168A
To provide a compound for inhibiting mammalian tumor cell proliferation.A compound for inhibiting mammalian tumor cell proliferation is a compound (I) having a structure shown in a chemical formula, wherein n is an integer from 0 to 9. T...  
JP2013533219A  
JP2013155194A
To provide compositions and methods useful for treatment or suppression of diseases due to mitochondrial disorders, such as Friedreich's ataxia, Leber's Hereditary Optic Neuropathy, Kearns-Sayre Syndrome, and mitochondrial myopathy, ence...  
JP2013522217A  
JP2013515712A  
JP5192541B2  
JP5190865B2  

Matches 251 - 300 out of 2,213